Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thyroid stimulating hormone subunit beta (TSHB)
- Target
- TSHB
- Molecular classification
- Glycoprotein hormone subunit, Peptide hormone subunit, Other
01
Overview
Thyroid stimulating hormone subunit beta (TSHB) is a 118-amino acid glycoprotein subunit encoded by the TSHB gene on chromosome 1. TSHB combines with a common alpha subunit to form functional thyroid stimulating hormone (TSH), the principal pituitary hormone controlling thyroid gland development, growth, and hormone secretion. The beta subunit provides receptor specificity, ensuring that TSH activates the TSH receptor exclusively on thyroid cells. Mutations in TSHB can cause congenital central hypothyroidism due to impaired TSH secretion or activity, resulting in reduced thyroid hormone production and metabolic dysfunction. TSHB is tightly regulated by the hypothalamic-pituitary-thyroid axis and is frequently measured as part of routine screening and diagnosis of thyroid disorders
- Other names
- Thyrotropin beta chainTSHBTSH-BTSH-betaThyrotropin beta subunitThyroid-stimulating hormone subunit betaThyrotropin beta chain precursorTSH-BETATSHB_HUMAN
02
Mechanism of action
Recombinant TSHB as part of full TSH: Activates TSH receptor, stimulating the thyroid gland to produce thyroid hormones Thyroid hormone replacement: Compensates the downstream effect of insufficient TSH action, does not directly target TSHB or its receptor
03
Biological functions
Regulation of thyroid gland growth and functionStimulation of thyroid hormone (thyroxine/T4, triiodothyronine/T3) synthesis and releaseMetabolic control (through thyroid hormone action)Brain development and general organismal growth (via thyroid hormone)
04
Disease associations
Congenital hypothyroidism (mutations cause central—pituitary origin—hypothyroidism)Secondary hypothyroidismHashimoto's thyroiditis (associations with autoimmune thyroid dysfunction)
05
Safety considerations
Risk of hypothyroidism if defective: developmental delay, poor metabolism, impaired growthIn diagnostic/therapeutic recombinant use: possible allergic reactions, excessive thyroid stimulationAutoimmune disease risk (Hashimoto's thyroiditis)
06
Interacting drugs
Thyroid hormone replacement (levothyroxine, liothyronine—indirect interaction, given in hypothyroidism when TSHB/TSH deficiency occurs)
1 more in the full profile.
07
Biomarkers
Serum TSH level (reflects TSHB activity as part of the TSH heterodimer, heavily used diagnostically)TSHB gene mutations (genetic marker for congenital central hypothyroidism; used in patient selection and neonatal screening)
Beyond the preview
Go deeper on Thyroid stimulating hormone subunit beta (TSHB).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thyroid stimulating hormone subunit beta (TSHB).